Prognostic importance of histologic grading in ovarian carcinoma
Decker, D.G.; Malkasian, G.D.; Taylor, W.F.
National Cancer Institute Monograph 42: 9-11
1975
ISSN/ISBN: 0083-1921 PMID: 1234640 Document Number: 89755
Our data on ovarian epithelial carcinoma show that within a given stage, regardless of the histologic cell type, the increasingly higher grades have an increasingly poorer prognosis. This suggests that more intensive therapy be considered for all patients with ovarian epithelial carcinomas than is currently undertaken. Specifically, this means that, in addition to the standard modalities, chemotherapy should be considered for all tumors beyond grade 1, stage 1a.
Document emailed within 1 workday
Related Documents
Sorbe, B.; Frankendal, B.; Veress, B. 1982: Importance of histologic grading in the prognosis of epithelial ovarian carcinoma Obstetrics and Gynecology 59(5): 576-582Hostetter, A.; Pedersen, K.; Boeryd, B.; Gustafsson, B.; Månson, J.; Engberg, A. 1988: Prostate carcinoma investigated by whole organ sections using the Gleason histologic grading system Scandinavian Journal of Urology and Nephrology. Supplementum 110: 163-167
Lindahl, B.; Alm, P.; Fernö, M.; Grundsell, H.; Norgren, A.; Tropé, C. 1986: Relapse of endometrial carcinoma related to steroid receptor concentration, staging, histologic grading and myometrial invasion Anticancer Research 6(6): 1317-1320
Ventura, L.; Chiominto, A.; Discepoli, S.; Ventura, T.; Di Giacomo, C.; Leocata, P. 2002: Lack of prognostic significance in Goseki grading of gastric carcinoma Journal of Experimental and Clinical Cancer Research: Cr 21(2): 225-227
Zhang, J.; Guo, X.-q.; Liu, J.-s. 2011: Clinical significance of two-tier grading system of ovarian serous carcinoma Zhonghua Fu Chan Ke Za Zhi 46(10): 739-741
Helpap, B.; Knüpffer, J.; Essmann, S. 1990: Nucleolar grading of renal cancer. Correlation of frequency and localization of nucleoli to histologic and cytologic grading and stage of renal cell carcinomas Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 3(6): 671-678
Stauch, G.; Lellé, R.J.; Broermann, L.; Georgii, A. 1988: Comparison of prognostic factors in mammary carcinoma: grading malignancy according to Bloom and Richardson versus assay of the growth fraction using Ki67 Verhandlungen der Deutschen Gesellschaft für Pathologie 72: 256-259
Jancárková, N.; Krkavcová, M.; Janashia, M.; Freitag, P.; Dusková, J.; Cibula, D. 2008: Importance of chromosomal changes correlated to prognostic factors in ovarian and cervical malignant tumors Ceska Gynekologie 73(2): 79-86
Aure, J.C.; Hoeg, K.; Kolstad, P. 1971: Clinical and histologic studies of ovarian carcinoma. Long-term follow-up of 990 cases Obstetrics and Gynecology 37(1): 1-9
Seidman, J.D.; Berman, J.J.; Moore, G.W. 1991: Basal cell carcinoma: importance of histologic discontinuities in the evaluation of resection margins Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 4(3): 325-330
Kably Ambe, A.; García León, F.; Esparza Iturbide, J.; López Rivadeneyra, E. 1998: Prognostic importance of controlled ovarian hyperstimulation previous to therapeutic laparoscopy of infertile patients Ginecologia y Obstetricia de Mexico 66: 320-324
Goldhirsch, A.; Joss, R.; Greiner, R.; Brunner, K.W. 1980: Ovarian carcinoma: new prognostic and therapeutic viewpoints Schweizerische Medizinische Wochenschrift 110(44): 1597-1605
Vergote, I. 2001: Prognostic factors in stage i ovarian carcinoma Verhandelingen - Koninklijke Academie Voor Geneeskunde van Belgie 63(3): 257-271; Discussion: 272-276
Ohman, U.; Wetterfors, J.; Moberg, A. 1972: Histologic grading of gastric cancer Acta Chirurgica Scandinavica 138(4): 384-390
Menczer, J.; Schejter, E.; Geva, D.; Ginath, S.; Zakut, H. 1998: Ovarian carcinoma associated thrombocytosis. Correlation with prognostic factors and with survival European Journal of Gynaecological Oncology 19(1): 82-84
Katsaros, D.; Fracchioli, S.; Arts, H.J.; de Vries, E.G.; Danese, S.; Richiardi, G.; Arisio, R.; Gordini, G.; Van der Zee, A.G.; Suurmeijer, A.J.; Massobrio, M. 1999: Expression and prognostic value of the drug resistance markers P-gp, Mrp1, Mrp2, and Lrp in ovarian carcinoma Minerva Ginecologica 51(12): 463-470
Geisler, J.P.; Tammela, J.E.; Manahan, K.J.; Geisler, H.E.; Miller, G.A.; Zhou, Z.; Wiemann, M.C. 2004: HSP27 in patients with ovarian carcinoma: still an independent prognostic indicator at 60 months follow-up European Journal of Gynaecological Oncology 25(2): 165-168
Fischer-Colbrie, J.; Witt, A.; Heinzl, H.; Speiser, P.; Czerwenka, K.; Sevelda, P.; Zeillinger, R. 1997: EGFR and steroid receptors in ovarian carcinoma: comparison with prognostic parameters and outcome of patients Anticancer Research 17(1b): 613-619
Facchetti, F.; Buffoli, A.; Olivetti, L.; Viva, E. 1983: Cystic adenoid carcinoma of the minor salivary glands; prognostic importance of various histopathologic factors Pathologica 75(1039): 725-733
Penault-Llorca, F.; Levrel, O.; Clémenson, A.; Kwiatkowski, F.; Pomel, C.; Fouilhoux, G.; De Latour, M.; Curé, H.; Déchelotte, P.; Fonck, Y.; Dauplat, J. 2000: Assessment of different histoprognosis grading systems for primary ovarian cancer: 100 patients given the same treatment for primary ovarian adenocarcinoma Journal de Gynecologie Obstetrique et Biologie de la Reproduction 29(6): 548-554